These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36796947)

  • 1. Pathology vs pathogenesis: Rationale and pitfalls in the clinicopathology model of neurodegeneration.
    Donadio V; Sturchio A; Rizzo G; Abu Rumeileh S; Liguori R; Espay AJ
    Handb Clin Neurol; 2023; 192():35-55. PubMed ID: 36796947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology of Neurodegenerative Diseases.
    Dugger BN; Dickson DW
    Cold Spring Harb Perspect Biol; 2017 Jul; 9(7):. PubMed ID: 28062563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel therapeutic approaches to target neurodegeneration.
    de la Fuente AG; Pelucchi S; Mertens J; Di Luca M; Mauceri D; Marcello E
    Br J Pharmacol; 2023 Jul; 180(13):1651-1673. PubMed ID: 36965025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The shift to a proteinopenia paradigm in neurodegeneration.
    Ezzat K; Sturchio A; Espay AJ
    Handb Clin Neurol; 2023; 193():23-32. PubMed ID: 36803814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathological and biochemical investigation of Hereditary Ferritinopathy cases with ferritin light chain mutation: Prominent protein aggregation in the absence of major mitochondrial or oxidative stress.
    Kurzawa-Akanbi M; Keogh M; Tsefou E; Ramsay L; Johnson M; Keers S; Wsa Ochieng L; McNair A; Singh P; Khan A; Pyle A; Hudson G; Ince PG; Attems J; Burn J; Chinnery PF; Morris CM
    Neuropathol Appl Neurobiol; 2021 Feb; 47(1):26-42. PubMed ID: 32464705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequestration of cellular interacting partners by protein aggregates: implication in a loss-of-function pathology.
    Yang H; Hu HY
    FEBS J; 2016 Oct; 283(20):3705-3717. PubMed ID: 27016044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases.
    Yoshida S; Hasegawa T
    Neurochem Int; 2022 May; 155():105307. PubMed ID: 35181393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SGTA associates with intracellular aggregates in neurodegenerative diseases.
    Kubota S; Doi H; Koyano S; Tanaka K; Komiya H; Katsumoto A; Ikeda S; Hashiguchi S; Nakamura H; Fukai R; Takahashi K; Kunii M; Tada M; Takeuchi H; Tanaka F
    Mol Brain; 2021 Mar; 14(1):59. PubMed ID: 33757575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the cellular prion protein in the uptake and toxic signaling of pathological neurodegenerative aggregates.
    Scialò C; Legname G
    Prog Mol Biol Transl Sci; 2020; 175():297-323. PubMed ID: 32958237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neither a Novel Tau Proteinopathy nor an Expansion of a Phenotype: Reappraising Clinicopathology-Based Nosology.
    Marsili L; Sharma J; Espay AJ; Migazzi A; Abdelghany E; Hill EJ; Duque KR; Hagen MC; Stephen CD; Kovacs GG; Lang AE; Hadjivassiliou M; Basso M; Kauffman MA; Sturchio A
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrovascular pathology presenting as corticobasal syndrome: An autopsy case series of "vascular CBS".
    Koga S; Roemer SF; Kasanuki K; Dickson DW
    Parkinsonism Relat Disord; 2019 Nov; 68():79-84. PubMed ID: 31621626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein aggregation in Alzheimer's disease and other neoropathological disorders.
    Dimakopoulos AC
    Curr Alzheimer Res; 2005 Jan; 2(1):19-28. PubMed ID: 15977986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau pathology and neurodegeneration.
    Spillantini MG; Goedert M
    Lancet Neurol; 2013 Jun; 12(6):609-22. PubMed ID: 23684085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathology of basal ganglia in neurodegenerative diseases].
    Wakabayashi K; Tanji K; Mori F
    Brain Nerve; 2009 Apr; 61(4):429-39. PubMed ID: 19378813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein aggregation and neurodegenerative diseases: From theory to therapy.
    Kumar V; Sami N; Kashav T; Islam A; Ahmad F; Hassan MI
    Eur J Med Chem; 2016 Nov; 124():1105-1120. PubMed ID: 27486076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The overlap of corticobasal degeneration and Alzheimer changes: an autopsy case.
    Zhang W; Zheng R; Wang Z; Yuan Y
    Neuropathology; 2009 Dec; 29(6):720-6. PubMed ID: 19323789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive supranuclear palsy.
    Piras A; Collin L; Grüninger F; Graff C; Rönnbäck A
    Acta Neuropathol Commun; 2016 Mar; 4():22. PubMed ID: 26936765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of forensic thanatology through the prism of analysis of postmortem protocols collected at the Department of Forensic Medicine, Jagiellonian University].
    Konopka T
    Arch Med Sadowej Kryminol; 2011; 61(3):213-300. PubMed ID: 22393873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathology of synuclein aggregates.
    Duda JE; Lee VM; Trojanowski JQ
    J Neurosci Res; 2000 Jul; 61(2):121-7. PubMed ID: 10878583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain banking for neurodegenerative diseases.
    Murphy DD; Ravina B
    Curr Opin Neurol; 2003 Aug; 16(4):459-63. PubMed ID: 12869803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.